Trial Profile
Comparative evaluation of thienopyridines on platelet aggregation in patients with ischemic heart disease in multi-centers in Okinawa
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 09 May 2022
Price :
$35
*
At a glance
- Drugs Clopidogrel (Primary) ; Prasugrel (Primary)
- Indications Coronary artery disease; Ischaemic heart disorders
- Focus Therapeutic Use
- Acronyms CHIMU Okinawa Study
- 28 Jan 2021 Status changed from active, no longer recruiting to completed.
- 27 Dec 2018 Planned number of patients changed from 200 to 160.
- 27 Dec 2018 Status changed from not yet recruiting to active, no longer recruiting.